Cytokine and chemokine ligand expression in cutaneous lupus erythematosus

European Journal of Dermatology

Volumn 22, Issue 3, 2012, Pages 319-323

  Gambichler, Thilo ^a   Genc, Zanna ^a   Skrygan, Marina ^a   Scola, Nina ^a   Tigges, Christian ^a   Terras, Sarah ^a   Bechara, Falk G ^a   Kreuter, Alexander ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Chemokines; Cytokines; INF ; Lupus erythematosus; TGF ; TNF

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOKINE; CXCL9 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 6; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALPHA INTERFERON GENE; ARTICLE; BETA INTERFERON GENE; CHEMOKINE GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CXCL9 CHEMOKINE GENE; CYTOKINE GENE; CYTOKINE PRODUCTION; DISCOID LUPUS ERYTHEMATOSUS; FEMALE; GAMMA INTERFERON GENE; GAMMA INTERFERON INDUCIBLE PROTEIN 10 GENE; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE GENE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTERLEUKIN 10 GENE; INTERLEUKIN 12P40 GENE; INTERLEUKIN 18 GENE; INTERLEUKIN 6 GENE; LIGAND BINDING; MALE; MOLECULAR PATHOLOGY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL; TRANSFORMING GROWTH FACTOR BETA GENE; TUMOR NECROSIS FACTOR ALPHA GENE;

ADULT; AGED; AGED, 80 AND OVER; CHEMOKINES; CHRONIC DISEASE; CYTOKINES; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84863196435     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1725     Document Type: Article

References (20)

1. Kuhn A, Ruzicka, T. Classification of cutaneous lupus erythematosus. In Kuhn A, Lehmann P, Ruzicka T, eds. Cutaneous lupus erythematosus. Germany: Springer, 2005; 5.
2. Kuhn A, Bijl M. Pathogenesis of cutaneous lupus erythematosus. Lupus 2008; 17: 389.
3. Lin JH, Dutz JP, Sontheimer RD, Werth VP. Pathophysiology of cutaneous Lupus Erythematosus. Clinic Rev Allerg Immunol 2007; 33: 85.
4. Kuhn A, Sonntag M, Richter-Hintz D, et al. Phototesting in lupus erythematosus: a 15 year experience. J Am Acad Dermatol 2001; 45: 86.
5. Stein LF, Saed GM, Fivenson DP. T-cell cytokine network in cutaneous lupus erythematosus. J Am Acad Dermatol 1997; 36: 191.
6. Toro JR, Finlay D, Dou X, Zheng SC, LeBoit PE, Connolly MK. Detection of type I cytokines in discoid lupus erythematosus. Arch Dermatol 2000; 136: 1497.
7. Wenzel J, Woren-Kamper E, Freutel S, et al. Enhanced type I interferon signalling promotes ThI-biased inflammation in cutaneous lupus erythematosus. J Pathol 2005; 205:435.
8. Werth VP, Zhang W, Dortzbach K, Sullivan K. Association of a promoter polymorphism of Tumor Necrosis Factor-a with Subacute Cutaneous Lupus Erythematosus and distinct photoregulation of transcription. J Invest Dermatol 2000; 115:726.
9. Rahman A. Cytokines in systemic lupus erythematosus. Arthritis Res Ther 2003; 5: 160.
10. Singh AK. Cytokines play a central role in the pathogenesis of systemic lupus erythematosus. Med Hypotheses 1992; 39: 356.
11. Kreuter A, Jaouhar M, Skrygan M, Tigges C, Stücker M, Altmeyer P, et al. Expression of antimicrobial peptides in different subtypes of cutaneous lupus erythematosus. J Am Acad Dermatol 2011; 65:125-133.
12. Gambichler T, Skrygan M, Tomi NS, et al. Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int Arch Allergy Immunol. 2008; 147:17-24.
13. Marques ER, Lourenco SV, Lima DM, Nico MM. Oral lesions in lupus erythematosus-cytokines profiles of inflammatory infiltrate. J Cutan Pathol 2010; 37:439-445.
14. Aringer M, Smolen JS. SLE-Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus. Arthritis Res Ther 2003; 5: 172.
15. Williams EL, Gadola S, Edwards CJ. Anti-TNF-induced lupus. Rheumatology (Oxford) 2009; 48: 716.
16. Uppal S, Hayat S, Raghupathy R. Efficacy and safety of infliximab in active SLE: a pilot study. Lupus 2009; 18: 690.
17. Wang D, Drenker M, Eiz-Vesper B, Werfel T, Wittmann M. Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus. Arthritis Rheum 2008; 58: 3205-3215.
18. Whiting D, Hsieh G, Yun JJ, et al. Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J Immunol 2004; 172: 7417-7424.
19. Meller S, Winterberg F, Gilliet M, et al. Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 2005; 52:1504-1516.
20. Wenzel J, Zahn S, Mikus S, Wiechert A, Bieber T, Tüting T. The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets. Br J Dermatol 2007; 157: 752-757.